Influenza A virus subtype H7N2

From WikiMD's WELLNESSPEDIA

Influenza A virus subtype H7N2 is a subtype of the Influenza A virus that has been identified as a potential cause of human pandemic. This subtype, like other Influenza A virus subtypes, is a part of the Orthomyxoviridae family of viruses.

Overview[edit]

Influenza A virus subtype H7N2 is a strain of the influenza virus that primarily affects birds, but can occasionally infect humans and other animals. The virus is characterized by the combination of H7 Hemagglutinin and N2 Neuraminidase, two key proteins that determine the virus's subtype.

Infection and Transmission[edit]

The primary hosts of H7N2 are birds, particularly domestic poultry. The virus is transmitted through direct contact with infected birds or their droppings, or through the air via droplets or dust particles. Human infections are rare, but have occurred, usually in people who have direct contact with infected birds.

Symptoms and Treatment[edit]

In birds, H7N2 can cause a wide range of symptoms, from mild illness to severe disease and death. In humans, the symptoms of H7N2 infection are similar to those of other forms of flu, including fever, cough, sore throat, and muscle aches. Treatment typically involves supportive care, including rest, hydration, and over-the-counter medications to relieve symptoms. In some cases, antiviral drugs may be used.

Prevention and Control[edit]

Prevention of H7N2 infection in birds involves good biosecurity practices, including regular cleaning and disinfection of poultry houses, and vaccination of poultry. In humans, prevention involves avoiding close contact with infected birds. Control measures include culling of infected birds and vaccination of poultry.

See Also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.